Biomerieux drops as it warns of larger FX impact on 2025 CEBIT

Biomerieux SA

17/04/2025 08:53

** Shares in Biomerieux BIOX.PA drop more than 5% after the French in-vitro diagnostics firm said currency exchange (FX) would have larger impact on 2025 core earnings than previously guided

** It confirms 2025 guidance for sales and contributive operating income before non-recurring items (CEBIT)

** However, it expects FX to have a negative impact of around 35-40 million euros ($39.8-45.5 million) on 2025 CEBIT vs around 30 million before

** It posts Q1 sales of 1.10 billion euros, up 12.7% organically

** Shares on track for worst day since September 2022 if the losses hold

** They are among top fallers on France's SBF 120 index .SBF120

($1 = 0.8796 euros)

 (Reporting by Michal Aleksandrowicz)

 ((michal.aleksandrowicz@tr.com))